REF
9416
Description
Real time PCR test with retrotranscription included for the detection of SARS-CoV-2 (2019-nCoV), Influenza A and B in respiratory samples
Packaging
96 test
Certification
Respiratory infections can be viral and/or bacterial and may present non-specific symptoms. Therefore, a diagnostic tool enables to determine quickly the cause of infection is essential for rapid intervention and a correct therapy. Moreover, syndromic panels are indispensable in respiratory diseases, which are usually seasonal, to control and stop any eventual outbreaks.
Technology
Multiplexing technology
Target
Mastermix number
1
Internal control
Exogenous
UDG
Yes
Fluorophores
Limit of Detection (LoD)
See technical data sheet
Analytical specificity
A wide range of pathogens was used to test the assay. No cross-reactivity was found.
Diagnostic sensitivity
100 % for all pathogens
Diagnostic specificity
100 % SARS-CoV-2, 98.23 % Flu A, 99.18 % Flu B
Riproducibility
100 %
Specimen
Validated thermalcyclers
Software
NeoPlex Viewer/Easy-NAT
Fill out the form and send us your request.
Sarà nostra cura risponderti al più presto.
"*" indicates required fields